Role of tumor microenvironment in the formation and progression of skin melanoma;Rola mikrośrodowiska nowotworowego w powstaniu i progresji czerniaka skóry

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 413-432

  Olbryt, Magdalena ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Hypoxia; Skin melanoma; Tumor microenvironment

Indexed keywords

ANIMAL; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE COURSE; DISEASE MODEL; FIBROBLAST; HUMAN; KERATINOCYTE; MELANOCYTE; MELANOMA; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; SKIN; SKIN TUMOR; TUMOR INVASION; TUMOR MICROENVIRONMENT; ULTRAVIOLET RADIATION;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBROBLASTS; HUMANS; KERATINOCYTES; MELANOCYTES; MELANOMA; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SKIN; SKIN NEOPLASMS; TUMOR MICROENVIRONMENT; ULTRAVIOLET RAYS;

EID: 84883886525     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1049286     Document Type: Article

References (148)

1. Akgül B., García-Escudero R., Ekechi C., Steger G., Navsaria H., Pfister H., Storey A.: The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures. Med. Microbiol. Immunol., 2011;200:127-135
2. Alonso S. R., Tracey L., Ortiz P., Pérez-Gómez B., Palacios J., Pollán M., Linares J., Serrano S., Sáez-Castillo A. I., Sánchez L., Pajares R., Sánchez-Aguilera A., Artiga M. J., Piris M. A., Rodríguez-Peralto J. L.: A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res., 2007;67:3450-3460
3. Ariyanayagam-Baksh S. M., Baksh F. K., Swalsky P. A., Finkelstein S. D.: Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Mod. Pathol., 2003;16:992-995
4. Balsamo M., Scordamaglia F., Pietra G., Manzini C., Cantoni C., Boitano M., Queirolo P., Vermi W., Facchetti F., Moretta A., Moretta L., Mingari M. C., Vitale M.: Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc. Natl. Acad. Sci. USA, 2009;106:20847-20852
5. Basu B., Biswas S., Wrigley J., Sirohi B., Corrie P.: Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies. Expert. Rev. Anticancer Ther., 2009;9:1583-1598
6. Bedogni B., Powell M. B.: Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin. Pigment Cell Melanoma Res., 2009;22:166-174
7. Bedogni B., Warneke J. A., Nickoloff B. J., Giaccia A. J., Powell M. B.: Notch1 is an effector of Akt and hypoxia in melanoma development. J. Clin. Invest., 2008;118:3660-3670
8. Bedogni B., Welford S. M., Cassarino D. S., Nickoloff B. J., Giaccia A. J., Powell M. B.: The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell, 2005;8:443-454
9. Belleudi F., Cardinali G., Kovacs D., Picardo M., Torrisi M. R.: KGF promotes paracrine activation of the SCF/c-KIT axis from human keratinocytes to melanoma cells. Transl. Oncol., 2010;3:80-90
10. Bertout J. A., Patel S. A., Simon M. C.: The impact of O2 availability on human cancer. Nat. Rev. Cancer, 2008;8:967-975
11. Bianchini F., Massi D., Marconi C., Franchi A., Baroni G., Santucci M., Mannini A., Mugnai G., Calorini L.: Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression. Prostaglandins Other Lipid Mediat., 2007;83:320-328
12. Bierie B., Moses H. L.: Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer, 2006;6, 506-520
13. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., Sampas N., Dougherty E., Wang E., Marincola F., Gooden C., Lueders J., Glatfelter A., Pollock P., Carpten J., Gillanders E., Leja D., Dietrich K., Beaudry C., Berens M., Alberts D., Sondak V.: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 2000;406:536-540
14. Boone B., Blokx W., De Bacquer D., Lambert J., Ruiter D., Brochez L.: The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch., 2008;453:257-265
15. Bronkhorst I. H., Ly L. V., Jordanova E. S., Vrolijk J., Versluis M., Luyten G. P., Jager M. J.: Detection of M2-macrophages in uveal melanoma and relation with survival. Invest. Ophthalmol. Vis Sci., 2011;52:643-650
16. Brown E. R., Doig T., Anderson N., Brenn T., Doherty V., Xu Y., Bartlett J. M., Smyth J. F., Melton D. W.: Association of galectin-3 expression with melanoma progression and prognosis. Eur. J. Cancer, 2012;48:865-874
17. Buback F., Renkl A. C., Schulz G., Weiss J. M.: Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp. Dermatol., 2009;18:750-759
18. Buscà R., Berra E., Gaggioli C., Khaled M., Bille K., Marchetti B., Thyss R., Fitsialos G., Larribère L., Bertolotto C., Virolle T., Barbry P., Pouysségur J., Ponzio G., Ballotti R.: Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J. Cell Biol., 2005;170:49-59
19. Caldarola G., Battista C., Pellicano R.: Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. Clin. Ther., 2010;32:57-59
20. Cangara H. M., Ishida T., Hara T., Sun L., Toh R., Rikitake Y., Kundu R. K., Quertermous T., Hirata K., Hayashi Y.: Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis. Microvasc. Res., 2010;80:133-141
21. Chen W., Ma T., Shen X. N., Xia X. F., Xu G. D., Bai X. L., Liang T. B.: Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway. Cancer Res., 2012;72:1363-1372
22. Cheung M., Sharma A., Madhunapantula S. V., Robertson G. P.: Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Res., 2008;68:3429-3439
23. Ch'ng S., Tan S. T.: Genetics, cellular biology and tumor microenvironment of melanoma. Front. Biosci., 2009;14:918-928
24. Cipponi A., Wieers G., van Baren N., Coulie P. G.: Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why? Cancer Immunol. Immunother.: 2011;60:1153-1160
25. Clark W. H. Jr., Elder D. E., Guerry D.4th., Epstein M. N., Greene M. H., Van Horn M.: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol., 1984;15:1147-1165
26. Cornil I., Theodorescu D., Man S., Herlyn M., Jambrosic J., Kerbel R. S.: Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA, 1991;88:6028-6032
27. Corrie P. G., Basu B., Zaki K. A.: Targeting angiogenesis in melanoma: prospects for the future. Ther. Adv. Med. Oncol., 2010;2:367-380
28. Cranfield F. D., Douglas C. M.: Young, pregnant and dying - how can we provide the "right" care? Med. J. Aust.: 2009;191:616-617
29. Daurkin I., Eruslanov E., Stoffs T., Perrin G. Q., Algood C., Gilbert S. M., Rosser C. J., Su L. M., Vieweg J., Kusmartsev S.: Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res., 2011;71:6400-6409
30. Defresne F., Bouzin C., Grandjean M., Dieu M., Raes M., Hatzopoulos A. K., Kupatt C., Feron O.: Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis. Cancer Res., 2011;71:4748-4757
31. Dewhirst M. W.: Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiat. Res., 2009;172:653-665
32. Evans S. M., Schrlau A. E., Chalian A. A., Zhang P., Koch C. J.: Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding. J. Invest. Dermatol., 2006;126:2596-2606
33. Facciabene A., Peng X., Hagemann I. S., Balint K., Barchetti A., Wang L. P., Gimotty P. A., Gilks C. B., Lal P., Zhang L., Coukos G.: Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T (reg) cells. Nature, 2011;475:226-230
34. Fröhlich E.: Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target. Cell Mol. Life Sci., 2010;67:3947-3960
35. Ghislin S., Obino D., Middendorp S., Boggetto N., Alcaide-Loridan C, Deshayes F.: Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro Pigment Cell Melanoma Res., 2011;24:504-511
36. Giatromanolaki A., Sivridis E., Kouskoukis C, Gatter K. C., Harris A. L., Koukourakis M. I.: Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res., 2003;13:493-501
37. Goetz J. G., Minguet S., Navarro-Lérida I., Lazcano J. J., Samaniego R., Calvo E., Tello M., Osteso-Ibáñez T., Pellinen T., Echarri A., Cerezo A., Klein-Szanto A. J., Garcia R., Keely P. J., Sánchez-Mateos P., Cukierman E., Del Pozo M. A.: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell, 2011;146:148-163
38. Gupta A., Driscoll M. S.: Do hormones influence melanoma? Facts and controversies. Clin. Dermatol, 2010;28:287-292
39. Haass N. K., Herlyn M.: Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J. Investig. Dermatol. Symp. Proc, 2005;10:153-163
40. Handerson T., Berger A., Harigopol M., Rimm D., Nishigori C, Ueda M., Miyoshi E., Taniguchi N., Pawelek J.: Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma. J. Cutan. Pathol, 2007;34:679-686
41. Harlin H., Meng Y., Peterson A. C., Zha Y., Tretiakova M., Slingluff C, McKee M., Gajewski T. F.: Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res., 2009;69:3077-3085
42. Hartmann P., Mirtolouei R., Untersberger S., Ziegler W., Hermann Z., Richtig E., Hofmann-Wellenhof R., Grinschgl S., Kerl H., Smolle J.: Non-invasive imaging of tissue PO2 in malignant melanoma of the skin. Melanoma Res., 2006;16:479-486
43. Hasumi Y, Kłosowska-Wardega A., Furuhashi M., Ostman A., Heldin C. H., Hellberg C: Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Int. J. Cancer, 2007;121:2606-2614
44. Hegde U. P., Chakraborty N., Kerr P., Grant-Kels J. M.: Melanoma in the elderly patient: relevance of the aging immune system. Clin. Dermatol, 2009;27:537-544
45. Helfrich I., Edler L., Sucker A., Thomas M., Christian S., Schadendorf D., Augustin H. G.: Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin. Cancer Res., 2009;15:1384-1392
46. Helfrich I., Schadendorf D.: Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance? Mol Oncol: 2011;5:137-149
47. Hendrix M. J., Seftor E. A., Hess A. R., Seftor R. E.: Molecular plasticity of human melanoma cells. Oncogene, 2003;22:3070-3075
48. Héroult M., Schaffner F., Pfaff D., Prahst C, Kirmse R., Kutschera S., Riedel M., Ludwig T., Vajkoczy P., Graeser R., Augustin H. G.: EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2. Mol. Cancer Res., 2010;8:1297-1309
49. Hoek K. S., Eichhoff O. M., Schlegel N. C., Döbbeling U., Kobert N., Schaerer L., Hemmi S., Dummer R.: In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res., 2008;68:650-656
50. Hoek K. S., Goding C. R.: Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res., 2010;23:746-759
51. Hoek K. S., Schlegel N. C., Brafford P., Sucker A., Ugurel S., Kumar R., Weber B. L., Nathanson K. L., Phillips D. J., Herlyn M., Schadendorf D., Dummer R.: Metastatic potential of melanomas defned by specific gene expression profles with no BRAF signature. Pigment Cell Res., 2006;19:290-302
52. Hsu M. Y., Meier F. E., Nesbit M., Hsu J. Y., Van Belle P., Elder D. E., Herlyn M.: E-cadherin expression in melanoma cells restores keratinocyte- mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol, 2000;56:1515-1525
53. Hsu M. Y., Shih D. T., Meier F. E., Van Belle P., Hsu J. Y., Elder D. E., Buck C. A., Herlyn M.: Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am. J. Pathol, 1998;153:1435-1442
54. Huang B., Lei Z., Zhang G. M., Li D., Song C, Li B., Liu Y, Yuan Y, Unkeless J., Xiong H., Feng Z. H.: SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood, 2008;112:1269-1279
55. Huber M. A., Kraut N., Park J. E., Schubert R. D., Rettig W. J., Peter R. U., Garin-Chesa P. Fibroblast activation protein: diferential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J. Invest. Dermatol, 2003;120:182-188
56. Hyter S., Bajaj G., Liang X., Barbacid M., Ganguli-Indra G., Indra A. K.: Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas. Pigment Cell Melanoma Res., 2010;23:635-648
57. Jaeger J., Koczan D., Thiesen H. J., Ibrahim S. M., Gross G., Spang R., Kunz M.: Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin. Cancer Res., 2007;13:806-815
58. Jager M. J., Ly L. V, El Filali M., Madigan M. C.: Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes? Prog. Retin. Eye Res., 2011;30:129-146
59. Jamal S., Schneider R. J.: UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. Clin. Invest, 2002;110:443-452
60. Kenneth N. S., Rocha S.: Regulation of gene expression by hypoxia. Biochem. J., 2008;414:19-29
61. Khosrotehrani K., Nguyen H. S., Prignon A., Avril M. F., Boitier F., Oster M., Mortier L., Richard M. A., Maubec E., Kerob D., Mansard S., Merheb C, Moguelet P., Nassar D., Guégan S., Aractingi S.: Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am. J. Pathol, 2011;178:1870-1880
62. Kim M., Koh Y. J., Kim K. E., Koh B. I., Nam D. H., Alitalo K., Kim I., Koh G. Y.: CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res., 2010;70:10411-10421
63. Kippenberger S., Loitsch S., Thaçi D., Müller J., Guschel M., Kaufmann R., Bernd A.: Restoration of E-cadherin sensitizes human melanoma cells for apoptosis. Melanoma Res., 2006, 16:393-403
64. Kirschmann D. A., Seftor E. A., Fong S. F., Nieva D. R., Sullivan CM., Edwards E. M., Sommer P., Csiszar K., Hendrix M. J.: A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res., 2002;62:4478-4483
65. Kluk M. J., Grant-Kels J. M., Kerr P., Hoss D., Berke A., Claffey K. P., Murphy M.: Melanoma on the move: the progression of melanoma: novel concepts with histologic correlates. Am. J. Dermatopathol, 2004;26:504-510
66. Koefnger P., Wels C, Joshi S., Damm S., Steinbauer E., Beham-Schmid C, Frank S., Bergler H, Schaider H.: The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators. Pigment Cell Melanoma Res., 2011;24:382-385
67. Koh M. Y., Darnay B. G., Powis G.: Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradation. Mol. Cell Biol., 2008;28:7081-7095
68. Kumar S. M., Yu H., Edwards R., Chen L., Kazianis S., Brafford P., Acs G., Herlyn M., Xu X.: Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res., 2007;67:3177-3184
69. Kunz M., Ibrahim S., Koczan D., Thiesen H. J., Köhler H. J., Acker T., Plate K. H., Ludwig S., Rapp U. R., Bröcker E. B., van Muijen G. N., Flory E., Gross G.: Activation of c-Jun. NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. Cell Growth Differ., 2001;12:137-145
70. Kunz M., Moeller S., Koczan D., Lorenz P., Wenger R. H., Glocker M. O., Thiesen H. J., Gross G., Ibrahim S. M.: Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J. Biol. Chem., 2003;278:45651-45660
71. Kuphal S., Winklmeier A., Warnecke C., Bosserhof A. K.: Constitutive HIF-1 activity in malignant melanoma. Eur. J. Cancer, 2010;46:1159-1169
72. Labrousse A. L., Ntayi C., Hornebeck W., Bernard P.: Stromal reaction in cutaneous melanoma. Crit. Rev. Oncol. Hematol., 2004;49:269-275
73. Ladányi A., Kiss J., Mohos A., Somlai B., Liszkay G., Gilde K., Fejos Z., Gaudi I., Dobos J., Tímár J.: Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol. Immunother., 2011;60:1729-1738
74. Langer H. F., Orlova V. V., Xie C., Kaul S., Schneider D., Lonsdorf A. S., Fahrleitner M., Choi E. Y., Dutoit V., Pellegrini M., Grossklaus S., Nawroth P. P., Baretton G., Santoso S., Hwang S. T., Arnold B., Chavakis T.: A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis. Cancer Res., 2011;71:4096-4105
75. Lartigau E., Randrianarivelo H., Avril M. F., Margulis A., Spatz A., Eschwège F., Guichard M.: Intratumoral oxygen tension in metastatic melanoma. Melanoma Res., 1997;7:400-406
76. Lazova R., Chakraborty A., Pawelek J. M.: Leukocyte-cancer cell fusion: initiator of the warburg effect in malignancy? Adv. Exp. Med. Biol., 2011;714:151-172
77. Lee J., Fassnacht M., Nair S., Boczkowski D., Gilboa E.: Tumor immunotherapy targeting fiobroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res., 2005;65:11156-11163
78. Lee J. T., Herlyn M.: Microenvironmental influences in melanoma progression. J. Cell Biochem., 2007;101:862-872
79. Li G., Fukunaga M., Herlyn M.: Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding β-catenin signaling. Exp. Cell Res., 2004;297:142-151
80. Li G., Satyamoorthy K., Herlyn M.: Dynamics of cell interactions and communications during melanoma development. Crit. Rev. Oral Biol. Med., 2002;13:62-70
81. Liang S., Hoskins M., Dong C.: Tumor cell extravasation mediated by leukocyte adhesion is shear rate dependent on IL-8 signaling. Mol. Cell Biomech., 2010;7:77-91
82. Liu B., Ma J., Wang X., Su F., Li X., Yang S., Ma W., Zhang Y.: Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Anat. Rec. (Hoboken), 2008;291:1227-1235
83. Lu X., Kang Y.: Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res., 2010;16:5928-5935
84. Mahabeleshwar G. H., Byzova T. V.: Angiogenesis in melanoma. Semin. Oncol., 2007;34:555-565
85. Markovic S. N., Erickson L. A., Rao R. D., Weenig R. H., Pockaj B. A., Bardia A., Vachon C. M., Schild S. E., McWilliams R. R., Hand J. L., Laman S. D., Kottschade L. A., Maples W. J., Pittelkow M. R., Pulido J. S., Cameron J. D., Creagan E. T.: Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment.. Mayo Clin. Proc., 2007;82:490-513
86. Melnikova V. O., Bar-Eli M.: Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res., 2006;19:395-405
87. Mills C. N., Joshi S. S., Niles R. M.: Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol. Cancer, 2009;8:104
88. Monsel G., Ortonne N., Bagot M., Bensussan A., Dumaz N.: c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene, 2010;29:227-236
89. Mrochem J., Bartnik W.: Osteopontyna - nowy marker w chorobach nowotworowych. Wsp. Onkol., 2008;12:349-353
90. Müller M., Beck I. M., Gadesmann J., Karschuk N., Paschen A., Proksch E., Djonov V., Reiss K., Sedlacek R.: MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Mod. Pathol., 2010;23:511-521
91. Navarini-Meury A. A., Conrad C.: Melanoma and innate immunity - active inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines. Semin Cancer Biol., 2009;19:84-91
92. Nisancioglu M. H., Betsholtz C., Genové G.: The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Cancer Res., 2010;70:5109-5115
93. Noman M. Z., Janji B., Kaminska B., Van Moer K., Pierson S., Przanowski P., Buart S., Berchem G., Romero P., Mami-Chouaib F., Chouaib S.: Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res., 2011;71:5976-5986
94. Nys K., Maes H., Dudek A. M., Agostinis P.: Uncovering the role of hypoxia inducible factor-1α in skin carcinogenesis. Biochim. Biophys. Acta, 2011;1816:1-12
95. Nys K., Van Laethem A., Michiels C., Rubio N., Piette J. G., Garmyn M., Agostinis P.: A p38 (MAPK)/HIF-1 pathway initiated by UVB irradiation is required to induce Noxa and apoptosis of human keratinocytes. J. Invest. Dermatol., 2010;130:2269-2276
96. Orimo A., Weinberg R. A.: Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle, 2006;5:1597-1601
97. Osawa T., Muramatsu M., Watanabe M., Shibuya M.: Hypoxia and low-nutrition double stress induces aggressiveness in a murine model of melanoma. Cancer Sci., 2009;100:844-851
98. Ozerdem U.: Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in NG2 proteoglycan knockout mouse. Ophthalmic Res., 2006;38:251-254
99. Panelos J., Massi D.: Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol. Ther., 2009;8:1986-1993
100. Paradela S., Fonseca E., Pita-Fernandez S., Kantrow S. M., Goncharuk V. N., Ivan D., Herzog C. E., Sturgis E. M., Prieto V. G.: Melanoma under 18 years and pregnancy: report of three cases Eur. J. Dermatol., 2010;20:186-188
101. Pinnix C. C., Lee J. T., Liu Z. J., McDaid R., Balint K., Beverly L. J., Brafford P. A., Xiao M., Himes B., Zabierowski S. E., Yashiro-Ohtani Y., Nathanson K. L., Bengston A., Pollock P. M., Weeraratna A. T., Nickoloff B. J., Pear W. S., Capobianco A. J., Herlyn M.: Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res., 2009;69:5312-5320
102. Pisacane A. M., Risio M.: VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas. Melanoma Res., 2005;15:39-43
103. Pollard J. W.: Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 2004;4:71-78
104. Postovit L. M., Adams M. A., Lash G. E., Heaton J. P., Graham C. H.: Nitric oxide-mediated regulation of hypoxia-induced B16F10 melanoma metastasis. Int. J. Cancer, 2004;108:47-53
105. Prieto V. G., Mourad-Zeidan A. A., Melnikova V., Johnson M. M., Lopez A., Diwan A. H., Lazar A. J., Shen S. S., Zhang P. S., Reed J. A., Gershenwald J. E., Raz A., Bar-Eli M.: Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin. Cancer Res., 2006;12:6709-6715
106. Puré E.: The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer. Expert Opin. Ther. Targets, 2009;13:967-973
107. Qi J., Nakayama K., Gaitonde S., Goydos J. S., Krajewski S., Eroshkin A., Bar-Sagi D., Bowtell D., Ronai Z.: The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA, 2008;105:16713-16718
108. Qian B. Z., Pollard J. W.: Macrophage diversity enhances tumor progression and metastasis. Cell, 2010;141:39-51
109. Ramirez-Montagut T., Blachere N. E., Sviderskaya E. V., Bennett D. C., Rettig W. J., Garin-Chesa P., Houghton A. N.: FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene, 2004;23:5435-5446
110. Rettig W. J., Garin-Chesa P., Healey J. H., Su S. L., Ozer H. L., Schwab M., Albino A. P., Old L. J.: Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res., 1993;53:3327-3335
111. Roda J. M., Sumner L. A., Evans R., Phillips G. S., Marsh C. B., Eubank T. D.: Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. J. Immunol., 2011;187:1970-1976
112. Rofstad E. K., Galappathi K., Mathiesen B., Ruud E. B.: Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin. Cancer Res., 2007;13:1971-1978
113. Rofstad E. K., Gaustad J. V., Egeland T. A., Mathiesen B., Galappathi K.: Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int. J. Cancer, 2010;127:1535-1546
114. Rofstad E. K., Mathiesen B.: Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia, 2010;12:889-898
115. Roy M., Pear W. S., Aster J. C.: The multifaceted role of Notch in cancer. Curr. Opin. Genet. Dev., 2007;17:52-59
116. Ruiter D., Bogenrieder T., Elder D., Herlyn M.: Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol., 2002;3:35-43
117. Sacewicz I., Wiktorska M., Wysocki T., Niewiarowska J.: Mechanizmy angiogenezy nowotworowej. Postȩpy Hig. Med. Dośw., 2009;63:159-168
118. Sato T., Ishiko A., Saito M., Tanaka M., Ishimoto H., Amagai M.: Rapid growth of malignant melanoma in pregnancy. J. Dtsch. Dermatol. Ges., 2008;6:126-129
119. Seftor E. A., Brown K. M., Chin L., Kirschmann D. A., Wheaton W. W., Protopopov A., Feng B., Balagurunathan Y., Trent J. M., Nickoloff B. J., Seftor R. E., Hendrix M. J.: Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Cancer Res., 2005;65:10164-10169
120. Semenza G.: Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol., 2002;64:993-998
121. Sendoel A., Kohler I., Fellmann C., Lowe S. W., Hengartner M. O.: HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature, 2010;465:577-583
122. Sethi G., Shanmugam M. K., Ramachandran L., Kumar A. P., Tergaonkar V.: Multifaceted link between cancer and inflammation. Biosci. Rep., 2012;32:1-15
123. Shahrzad S., Bertrand K., Minhas K., Coomber B. L.: Induction of DNA hypomethylation by tumor hypoxia. Epigenetics, 2007;2:119-125
124. Shao H., Cai L., Grichnik J. M., Livingstone A. S., Velazquez O. C., Liu Z. J.: Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene, 2011;30:4316-4326
125. Shellman Y. G., Makela M., Norris D. A.: Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res., 2006;16:207-211
126. Shi L., Lei D., Ma C., Xu F., Li Y., Wang Y., Cong N., Liu D., Pan X. L. Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma. J. Int. Med. Res., 2010;38:1276-1286
127. Spinella F., Rosanò L., Di Castro V., Decandia S., Nicotra M. R., Natali P. G., Bagnato A.: Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Cancer Res., 2007;67:1725-1734
128. Stackpole C. W., Groszek L., Kalbag S. S.: Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia. J. Natl. Cancer Inst., 1994;86:361-367
129. Sullivan R., Graham C. H.: Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev., 2007;26:319-331
130. Sun B., Zhang D., Zhang S., Zhang W., Guo H., Zhao X.: Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett., 2007;249:188-197
131. Sun X., Cheng G., Hao M., Zheng J., Zhou X., Zhang J., Taichman R. S., Pienta K. J., Wang J.: CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev., 2010;29:709-722
132. Szala S., Jarosz M.: Nowotworowe naczynia krwionośne. Postȩ-py Hig. Med. Dośw., 2011;65:437-446
133. Tang A., Eller M. S., Hara M., Yaar M., Hirohashi S., Gilchrest B. A.: E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J. Cell Sci., 1994;107:983-992
134. Trisciuoglio D., Iervolino A., Zupi G., Del Bufalo D.: Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol. Biol. Cell, 2005;16:4153-4162
135. Troyanova P.: The role of trauma in the melanoma formation. J. BUON, 2002;7:347-350
136. Turner F. E., Broad S., Khanim F. L., Jeanes A., Talma S., Hughes S., Tselepis C., Hotchin N. A.: Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. J. Biol. Chem., 2006;281:21321-21331
137. Van Kilsdonk J. W., Bergers M., Van Kempen L. C., Schalkwijk J., Swart G. W. Keratinocytes drive melanoma invasion in a reconstructed skin model. Melanoma Res., 2010;20:372-380
138. Victor N., Ivy A., Jiang B. H., Agani F. H.: Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells. Clin. Exp. Metastasis, 2006;23:87-96
139. Villanueva J., Herlyn M.: Melanoma and the tumor microenvironment. Curr. Oncol. Rep., 2008;10:439-446
140. Wandel E., Grasshoff A., Mittag M., Haustein U. F., Saalbach A.: Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. Exp. Dermatol., 2000;9:34-41
141. Wang E., Miller L. D., Ohnmacht G. A., Mocellin S., Perez-Diez A., Petersen D., Zhao Y., Simon R., Powell J. I., Asaki E., Alexander H. R., Duray P. H., Herlyn M., Restifo N. P., Liu E. T., Rosenberg S. A., Marincola F. M.: Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res., 2002;62:3581-3586
142. Wäster P., Rosdahl I., Gilmore B. F., Seifert O.: Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: implications for melanoma invasion. Int. J. Oncol., 2011;39:193-202
143. Winnepenninckx V., Lazar V., Michiels S., Dessen P., Stas M., Alonso S. R., Avril M. F., Ortiz Romero P. L., Robert T., Balacescu O., Eggermont A. M., Lenoir G., Sarasin A., Tursz T., van den Oord J. J., Spatz A.: Melanoma Group of the European Organization for Research and Treatment of Cancer. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl. Cancer Inst., 2006;98:472-482
144. Wu F. H., Yuan Y., Li D., Lei Z., Song C. W., Liu Y. Y., Li B., Huang B., Feng Z. H., Zhang G. M.: Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-κB pathway. Oncol. Rep., 2010;24:693-699
145. Zhang S., Li M., Zhang D., Xu S., Wang X., Liu Z., Zhao X., Sun B.: Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma. Lab. Invest., 2009;89:575-586
146. Zigler M., Kamiya T., Brantley E. C., Villares G. J., Bar-Eli M.: PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res.: 2011;71:6561-6566
147. Zigler M., Villares G. J., Dobroff A. S., Wang H., Huang L., Braeuer R. R., Kamiya T., Melnikova V. O., Song R., Friedman R., Alani R. M., Bar-Eli M.: Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res., 2011;71:3494-3504
148. Zigrino P., Nischt R., Mauch C.: The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts. J. Biol. Chem., 2011;286:6801-6807